Clinical Trial Update: Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effectiveness and safety of Mucosta (rebamipide) for gastric ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• Mucosta (rebamipide)

Snippet

Sponsor: Otsuka Pakistan Limited | Conditions: Gastric Ulcer | Phase 3 | Status: COMPLETED